EuroAsia patents 2108550EA has been granted. The SensoDetects main portfolio is approved in the Euroasia (Armenia, Azerbaijan, Belarus, Kyrgyzstan, Kazakhstan, Moldova, Russia, Tajikistan and Turkmenistan) area. IP portfolio strenghtens through this in especially one very important market, Russia.
In these countries, there is similar problems in Psychiatry as in the rest of the world. Interest increase in mental health treatment where SensoDetect BERA can be used for “screening” or as a decision support. SensoDetect is now granted patents that further strengthens the protection in countries where there are multiple stakeholders concerning the SensoDetects platform BERA and associated analytical tools.
For further reading, go to AktieTorget.